Skip to main content

VICO · Vicore Pharma Holding AB · Financials

8.7200 SEK -0.2400 (-2.68%) At close · Oct 7
Market Cap
2.70B SEK
Shares
281.53M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Browse captured authority reports and their original financial labels

Revenue
3.82M -96.5%
FY2025 Revenue FY2021–FY2025
Net Income
-477.47M -183.1%
FY2025 Net Income FY2021–FY2025
Gross Margin
100% 0pp
FY2025 Gross Margin FY2024–FY2025
Operating Margin
-11851.87% -11674.3pp
FY2025 Operating Margin FY2024–FY2025
Operating Cash Flow
-375.74M -127.8%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021
SEK 3.82M 109.35M 0 0 0
SEK 3.82M 109.35M 0 0 0
SEK 390.35M 249.26M 276.29M 249.97M 271.81M
SEK — 0 7.67M 9.15M 1.4M
SEK 67.91M 50.44M 36.92M 28.38M 20.2M
SEK -452.39M -194.19M -321.51M -290.73M -294.82M
SEK 48.98M 8000 358K 476K 2.56M
SEK -477.47M -168.89M -311.33M -288.81M -296.74M
SEK 0 -256K -384K -384K -254K
SEK -477.47M -168.63M -310.94M -288.42M -296.48M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current lease liabilities 2023-12-31 SEK 0 ESEF Annual Report filed 2024-04-23
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.